Effect of crocetin on COVID-19

INTERVENTION: Intervention 1: Intervention group: In addition to the standard treatment regimen for COVID‐19, the crocetin capsule 22.5 mg (7.5 mg, three times a day) will be given for 2 weeks. Intervention 2: Control group: Patients on the standard treatment regimen for COVID‐19 will receive placebo capsules 3 times a day for 2 weeks. The placebo is formulated in capsules of the same shape and size as the drug capsules and contains inert ingredients. CONDITION: Covid‐19. ; COVID‐19 disease U07.1 PRIMARY OUTCOME: Time interval until clinical symptoms improve. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: time of recovery. SECONDARY OUTCOME: CRP. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: CRP kit. Fever. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Thermometer. Lymphopenia. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Cell counter device. INCLUSION CRITERIA: Patients with COVID‐19 symptoms Indication of home quarantine and outpatient medication